ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
$21.19 -0.07 (-0.3293%)
Analysed ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) News Sources
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
06-05-2026
yahoo.com
Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue Estimates
06-05-2026
yahoo.com
Acadia (ACAD) Q1 2026 Earnings Transcript
06-05-2026
fool.com
ACADIA Pharmaceuticals Q1 Earnings Call Highlights
06-05-2026
marketbeat.com
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
07-05-2026
yahoo.com
What ACADIA Pharmaceuticals (ACAD)'s Earnings Miss, EU Setback and R&D Transition Means For Shareholders
09-05-2026
yahoo.com
Earnings Miss: ACADIA Pharmaceuticals Inc. Missed EPS By 58% And Analysts Are Revising Their Forecasts
11-05-2026
yahoo.com
ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms
13-05-2026
marketbeat.com
Shareholders In ACADIA Pharmaceuticals (NASDAQ:ACAD) Should Look Beyond Earnings For The Full Story
14-05-2026
yahoo.com
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth
19-05-2026
marketbeat.com
What is the current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is $21.19.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is $-0.07.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is -0.3293%.
What is the most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is .
SEC-8K** Filing Available For ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.